The bill accelerates and standardizes veterans' access to FDA-approved non-opioid postoperative analgesics, trading faster patient benefit and simpler VA prescribing for higher near-term costs, a restricted funding source, and potential implementation strain on VA staff.
Veterans and VA patients will get faster, standardized access to FDA-approved non-opioid postoperative analgesics because the bill requires those products be added to the VA national formulary (timed with Medicare eligibility), improving pain-management options and simplifying prescribing/procurement across VA facilities.
The VA must implement the formulary update within 90 days, which should reduce administrative delays and get clinicians and patients access to new non-opioid options more quickly.
Taxpayers could face higher VA drug spending if newly added non-opioid products are costly and are rapidly adopted across the VA formulary.
The bill prohibits using the Cost of War Toxic Exposures Fund for these additions, removing one potential funding source and likely shifting costs onto other VA budgets or taxpayers.
The 90-day implementation requirement could strain VA pharmacy and procurement staff, increasing the risk of implementation errors or short-term disruptions to ordering and supply.
Based on analysis of 2 sections of legislative text.
Requires VA to add defined non-opioid pain drugs/biologics to the national formulary and drug standardization list on a set timeline and forbids using the Cost of War Toxic Exposures Fund for implementation.
Requires the Department of Veterans Affairs to add defined “non-opioid pain management drugs or biological products” to the VA national formulary and the Department’s drug standardization list. The VA must implement the change within 90 days of enactment and must add qualifying products no later than one year after they become eligible for specified Medicare temporary or separate payment authorities. The bill also bars using the Cost of War Toxic Exposures Fund to carry out these changes.
Introduced July 17, 2025 by Greg Landsman · Last progress July 17, 2025